单位(元)永赢医药创新智选混合发起C(015916)资产负债表 |
| 报告期 |
2026/6/30 |
2025/12/31 |
2025/6/30 |
2024/12/31 |
| 资产 |
| 银行存款 |
564,795,433 |
1,022,637,693 |
545,853,505 |
10,440,910 |
| 结算备付金 |
11,434,789 |
6,007,879 |
6,990,167 |
155,593 |
| 存出保证金 |
892,851 |
2,588,923 |
535,633 |
97,541 |
| 交易性金融资产 |
4,688,899,077 |
5,181,346,418 |
2,766,047,503 |
163,306,685 |
| 其中:股票投资 |
4,688,899,077 |
5,181,346,418 |
2,766,047,503 |
158,442,804 |
| 基金投资 |
- |
- |
- |
- |
| 债券投资 |
- |
- |
- |
4,863,882 |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
179,097,983 |
53,224,151 |
- |
784,552 |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
1,274,775 |
- |
725,442 |
- |
| 应收申购款 |
143,863,947 |
71,173,913 |
82,162,250 |
1,107,939 |
| 其他资产 |
- |
- |
- |
- |
| 资产总计 |
5,590,258,855 |
6,336,978,977 |
3,402,314,500 |
175,893,221 |
| 负债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
39,384,058 |
- |
28,890,446 |
1,200,661 |
| 应付赎回款 |
159,748,936 |
395,628,409 |
325,294,887 |
2,898,118 |
| 应付管理人报酬 |
5,028,095 |
6,745,795 |
2,613,155 |
175,081 |
| 应付托管费 |
209,504 |
281,075 |
108,881 |
7,295 |
| 应付销售服务费 |
1,390,887 |
1,871,042 |
773,505 |
49,475 |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
- |
- |
- |
- |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
1,685,395 |
1,805,506 |
1,815,513 |
259,379 |
| 负债合计 |
207,446,875 |
406,331,827 |
359,496,386 |
4,590,009 |
| 所有者权益 |
| 实收基金 |
3,534,254,665 |
3,779,554,481 |
1,998,173,733 |
190,094,509 |
| 未分配利润 |
1,848,557,315 |
2,151,092,669 |
1,044,644,381 |
-18,791,297 |
| 所有者权益合计 |
5,382,811,980 |
5,930,647,149 |
3,042,818,113 |
171,303,212 |
| 负债和所有者权益总计 |
5,590,258,855 |
6,336,978,977 |
3,402,314,500 |
175,893,221 |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。